Home
Agreements
Review and Analysis
Conference Calendar
Subscribe
Articles in section Royalties
<< Research & Development
2 articles
Technology Access >>
Pages
1
Astellas Divests Prosidion’s DPP-IV Inhibitor Patent Assets to Royalty Pharma
Published: 12 Jul-2011
By: Heather Cartwright
Abstract
Fulltext:
Volume: 2011 Issue: 7
Enzon Pharmaceuticals Sells 25% Interest in Hepatitis C Drug
Published: 7 Sep-2007
By: Business Review Editor
Abstract
Fulltext:
Volume: 2007 Issue: 87
Login
Login
Username:
Password:
Keep me logged in
Login Problems?
Subscribe
Journal Home
Table of Content: Current Issue
Commentaries
Last Issue PDF
Browse by Issue
Browse by Section
Business Commentaries
Cartoons
Company Profile
Conference Report
Deal Trackers
Distribution & Marketing
Editorial
Features
General
Joint Venture
Licensing
Mergers & Acquisitions
Opinion & Analysis
Research & Development
Royalties
Technology Access
Conference Calendar
Subscribe
About
Copyright Notice
Contact Us
RSS
IQVIA™ Pharma Deals: PharmaDeals Review: Browse by Section
RSS